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SUPPLEMENTARY NOTES
ABSTRACT:
This progress report summarizes the clinical activity of cord blood procurement and the preliminary analysis of the yield of the cord blood cells for the purpose of clinical transplantation. The purpose of collection and procurement of cord blood is for public use and will be accessible to all the stem cell transplantation centers worldwide. Cord blood is a readily available source of hematopoietic stem cells that is more accessible than other lived donors, since the cryopreserved cord blood units (CBU) have already been extensively characterized in term of tissue typing and screening for infectious disease markers. The CBU from minority donor, especially African/American, is particularly valuable because of difficulty with finding a matched donor and CBU allows less stringent matching. Thus, CBU is a rapid solution to patients who are in urgent need of stem cell transplantation and no living donor available. Our preliminary analysis of the collected CBUs shows significantly lower content of nucleated cells in CBUs from African/American mothers. We have not identified adverse maternal health variables associated with lower cell dose. Improvement of availability of CBUs will have to come from increase recruitment of donors. 
INTRODUCTION
The purpose of this research is to increase the efficiency of procurement of minority cord blood units for the clinical stem cell transplantation. In the first year of this project, we will focus our effort on the investigation of the total nucleated cell yield of the cord blood units (CBUs) from African/American donors in comparison with other racial groups and to investigate the maternal health variables that might influence the total nucleated cell yield.
BODY
The ultimate purpose of this project is to be able to bank most of the African/American cord blood units from mothers delivering their babies in the Metropolitan Detroit areas. Therefore the strategy to capture the cord blood units from all the collaborating hospitals in the area is crucial to our success. To accomplish this, we have identified several hospitals to become collection sites for our cord blood bank. -30.864 7.596 -45.954 -15.773 Other maternal variables were explored including gravida and the frequency of prenatal clinic visit did not show any correlation with the nucleated cell yield. The only significant factor associated with total nucleated cell yield is the maternal race. The result of one-way ANOVA is shown below. 
KEY RESEARCH ACCOMPLISHMENTS
• Based on this preliminary analysis, the significant findings from this study are as follows:
• CBUs harvested from African/American mothers using in utero technique contained lower total nucleated cells than Caucasian mothers.
• There was no correlation of the cell yield with gravida, prenatal clinic visit and health variable.
• This study suggested that improvement of quality of CBUs may have to be compensated by better access to the collection sites and that expansion of the collections site will be most efficient.
• The strategy for donor recruitment will have to be formulated based on the current findings.
• Ongoing collection of the data on the total nucleated cell yield and further analyses of this dataset will be needed to better understand and refine the maternal health variables associated with nucleated cell yield.
REPORTABLE OUTCOMES
See KEY RESEARCH ACCOMPLISHMENT above.
CONCLUSION
In this preliminary analysis revealed the only maternal variable associated with total nucleated cell yield is maternal race. African/American donors had a lower nucleated cell yield and this did not appear to be correlated with the frequency of prenatal clinic visit. Obviously, lower nucleated cell count may be an inherent property of the African/American cord blood donor and there might not be any easy solution to improve the yield by improvement of prenatal clinic visit. Therefore, the practical solution is to increase the participation of African/American donor in the cord blood donation. We are presently designing a cord blood recruitment program targeting minority in the Metropolitan Detroit areas.
